1452 related articles for article (PubMed ID: 32302438)
21. Prominent coagulation disorder is closely related to inflammatory response and could be as a prognostic indicator for ICU patients with COVID-19.
Liu Y; Gao W; Guo W; Guo Y; Shi M; Dong G; Ge Q; Zhu J; Lu J
J Thromb Thrombolysis; 2020 Nov; 50(4):825-832. PubMed ID: 32761495
[TBL] [Abstract][Full Text] [Related]
22. Imbalance between procoagulant factors and natural coagulation inhibitors contributes to hypercoagulability in the critically ill COVID-19 patient: clinical implications.
Voicu S; Delrue M; Chousterman BG; Stépanian A; Bonnin P; Malissin I; Deye N; Neuwirth M; Ketfi C; Mebazaa A; Siguret V; Mégarbane B
Eur Rev Med Pharmacol Sci; 2020 Sep; 24(17):9161-9168. PubMed ID: 32965009
[TBL] [Abstract][Full Text] [Related]
23. The procoagulant pattern of patients with COVID-19 acute respiratory distress syndrome.
Ranucci M; Ballotta A; Di Dedda U; Baryshnikova E; Dei Poli M; Resta M; Falco M; Albano G; Menicanti L
J Thromb Haemost; 2020 Jul; 18(7):1747-1751. PubMed ID: 32302448
[TBL] [Abstract][Full Text] [Related]
24. Thromboelastography clot strength profiles and effect of systemic anticoagulation in COVID-19 acute respiratory distress syndrome: a prospective, observational study.
Bocci MG; Maviglia R; Consalvo LM; Grieco DL; Montini L; Mercurio G; Nardi G; Pisapia L; Cutuli SL; Biasucci DG; Gori C; Rosenkranz R; De Candia E; Carelli S; Natalini D; Antonelli M; Franceschi F
Eur Rev Med Pharmacol Sci; 2020 Dec; 24(23):12466-12479. PubMed ID: 33336766
[TBL] [Abstract][Full Text] [Related]
25. Global haemostatic tests in rapid diagnosis and management of COVID-19 associated coagulopathy in acute limb ischaemia.
Fan BE; Chia YW; Sum CLL; Kuperan P; Chan SSW; Ling LM; Tan GWL; Goh SSN; Wong LH; Lim SP; Lim KGE; Tan HT; Ang MK; Lau SL; Ong KH; Ng J
J Thromb Thrombolysis; 2020 Aug; 50(2):292-297. PubMed ID: 32474758
[No Abstract] [Full Text] [Related]
26. Inference from longitudinal laboratory tests characterizes temporal evolution of COVID-19-associated coagulopathy (CAC).
Pawlowski C; Wagner T; Puranik A; Murugadoss K; Loscalzo L; Venkatakrishnan AJ; Pruthi RK; Houghton DE; O'Horo JC; Morice WG; Williams AW; Gores GJ; Halamka J; Badley AD; Barnathan ES; Makimura H; Khan N; Soundararajan V
Elife; 2020 Aug; 9():. PubMed ID: 32804081
[TBL] [Abstract][Full Text] [Related]
27. COVID-19 and coagulation: bleeding and thrombotic manifestations of SARS-CoV-2 infection.
Al-Samkari H; Karp Leaf RS; Dzik WH; Carlson JCT; Fogerty AE; Waheed A; Goodarzi K; Bendapudi PK; Bornikova L; Gupta S; Leaf DE; Kuter DJ; Rosovsky RP
Blood; 2020 Jul; 136(4):489-500. PubMed ID: 32492712
[TBL] [Abstract][Full Text] [Related]
28. The haemostatic profile in critically ill COVID-19 patients receiving therapeutic anticoagulant therapy: An observational study.
Tsantes AE; Frantzeskaki F; Tsantes AG; Rapti E; Rizos M; Kokoris SI; Paramythiotou E; Katsadiotis G; Karali V; Flevari A; Chrysanthopoulou E; Maratou E; Kyriakou E; Gialeraki A; Bonovas S; Dimopoulos G; Tsangaris I; Armaganidis A
Medicine (Baltimore); 2020 Nov; 99(47):e23365. PubMed ID: 33217881
[TBL] [Abstract][Full Text] [Related]
29. The unique characteristics of COVID-19 coagulopathy.
Iba T; Levy JH; Connors JM; Warkentin TE; Thachil J; Levi M
Crit Care; 2020 Jun; 24(1):360. PubMed ID: 32552865
[TBL] [Abstract][Full Text] [Related]
30. COVID-19 coagulopathy: An in-depth analysis of the coagulation system.
Martín-Rojas RM; Pérez-Rus G; Delgado-Pinos VE; Domingo-González A; Regalado-Artamendi I; Alba-Urdiales N; Demelo-Rodríguez P; Monsalvo S; Rodríguez-Macías G; Ballesteros M; Osorio-Prendes S; Díez-Martín JL; Pascual Izquierdo C
Eur J Haematol; 2020 Dec; 105(6):741-750. PubMed ID: 32749010
[TBL] [Abstract][Full Text] [Related]
31. The clinical implication of dynamic neutrophil to lymphocyte ratio and D-dimer in COVID-19: A retrospective study in Suzhou China.
Fu J; Kong J; Wang W; Wu M; Yao L; Wang Z; Jin J; Wu D; Yu X
Thromb Res; 2020 Aug; 192():3-8. PubMed ID: 32407937
[TBL] [Abstract][Full Text] [Related]
32. Neutrophils and Contact Activation of Coagulation as Potential Drivers of COVID-19.
Busch MH; Timmermans SAMEG; Nagy M; Visser M; Huckriede J; Aendekerk JP; de Vries F; Potjewijd J; Jallah B; Ysermans R; Oude Lashof AML; Breedveld PH; van de Poll MCG; van de Horst ICC; van Bussel BCT; Theunissen ROMFIH; Spronk HMH; Damoiseaux JGMC; Ten Cate H; Nicolaes GAF; Reutelingsperger CP; van Paassen P
Circulation; 2020 Nov; 142(18):1787-1790. PubMed ID: 32946302
[No Abstract] [Full Text] [Related]
33. Characteristics of laboratory indexes in COVID-19 patients with non-severe symptoms in Hefei City, China: diagnostic value in organ injuries.
Li T; Wang L; Wang H; Gao Y; Hu X; Li X; Zhang S; Xu Y; Wei W
Eur J Clin Microbiol Infect Dis; 2020 Dec; 39(12):2447-2455. PubMed ID: 32613308
[TBL] [Abstract][Full Text] [Related]
34. Research in brief: Coagulopathy in COVID-19: Determining and managing thrombotic risk in COVID-19 infection.
Pooni RS
Clin Med (Lond); 2020 Jul; 20(4):e59. PubMed ID: 32675158
[No Abstract] [Full Text] [Related]
35. Enoxaparin for primary thromboprophylaxis in ambulatory patients with coronavirus disease-2019 (the OVID study): a structured summary of a study protocol for a randomized controlled trial.
Barco S; Bingisser R; Colucci G; Frenk A; Gerber B; Held U; Mach F; Mazzolai L; Righini M; Rosemann T; Sebastian T; Spescha R; Stortecky S; Windecker S; Kucher N
Trials; 2020 Sep; 21(1):770. PubMed ID: 32907635
[TBL] [Abstract][Full Text] [Related]
36. Coronavirus Disease 2019, Prothrombotic Factors, and Venous Thromboembolism.
Schulman S
Semin Thromb Hemost; 2020 Oct; 46(7):772-776. PubMed ID: 32392613
[No Abstract] [Full Text] [Related]
37. Rate of venous thromboembolism in a prospective all-comers cohort with COVID-19.
Rieder M; Goller I; Jeserich M; Baldus N; Pollmeier L; Wirth L; Supady A; Bode C; Busch HJ; Schmid B; Duerschmied D; Gauchel N; Lother A
J Thromb Thrombolysis; 2020 Oct; 50(3):558-566. PubMed ID: 32617807
[TBL] [Abstract][Full Text] [Related]
38. COVID-19-related laboratory coagulation findings.
Devreese KMJ
Int J Lab Hematol; 2021 Jul; 43 Suppl 1(Suppl 1):36-42. PubMed ID: 34288440
[TBL] [Abstract][Full Text] [Related]
39. The protective rather than prothrombotic fibrinogen in COVID-19 and other inflammatory states.
Thachil J
J Thromb Haemost; 2020 Aug; 18(8):1849-1852. PubMed ID: 32588535
[TBL] [Abstract][Full Text] [Related]
40. COVID-19 and SIC (!).
Nevzorov I; Tulamo R; Albäck A; Lassila R
J Vasc Surg; 2020 Sep; 72(3):1148-1150. PubMed ID: 32497749
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
